Category: Regulatory/FDA

Common Marketing Violations Still Occurring, OPDP Says in 2012 Q1 Enforcement Webinar

Guest Column: Heavy Meddle by Peter Pitts

Proposed OTC Drug Distribution Would Expand Patient Access to Rx Drugs

PDUFA V Bills Moving Forward Without Specific Marketing Provisions

CHC and TAC Comments Object to “Dual Modality” Risk Communication in DTC TV Ads

FDA Draft Guidance on DTC TV Ads Raises Important Questions

FTC to Industry: Adopt Consumer Privacy Best Practices Now

Call for Industry Comments: Proposed FDA Study on “Corrective” DTC TV Advertising

New Video Highlights Advances in CME Conflicts of Interest Policies